Ghana vs Pakistan: Cause of death, by non-communicable diseases, ages 0-4
Ghana
11.6%
in 2021
Pakistan
13.1%
in 2021
Ghana rank
140th
Pakistan rank
137th
Cause of death, by non-communicable diseases, ages 0-4 over time
- Ghana
- Pakistan
How they compare
Pakistan currently reports 13.1% against 11.6% in Ghana, a difference of 1.5%.
That makes Pakistan's figure about 1.1 times Ghana's.
Across all 6 years both countries report, Pakistan has been ahead every year.
Ghana ranks 140th and Pakistan ranks 137th of 185 countries.
Pakistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.0% | 6.8% | 1.9% | Pakistan |
| 2010s | 9.0% | 10.5% | 1.5% | Pakistan |
| 2020s | 11.4% | 13.0% | 1.6% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Ghana or Pakistan?
- Pakistan, at 13.1% against 11.6% in Ghana as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Ghana and Pakistan?
- 1.5%, with Pakistan ahead.
- How many years of comparable data are there for Ghana and Pakistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Ghana and Pakistan rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Ghana ranks 140th and Pakistan ranks 137th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.